Stay updated on Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial
Sign up to get notified when there's something new on the Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial page.

Latest updates to the Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates a minor backend or content rendering update to the page.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry, v3.6.5, was added to the revision history. The previous revision entry, v3.6.4, was removed.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page removes the sponsor listing for Astellas Pharma Europe B.V., a direct link to results on the Astellas Clinical Study Results site, and the 'Helpful Links Provided by' note in the Collaborators/Investigators area.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a maintenance update to the underlying revision. This change does not affect the visible content or data on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3, indicating a newer version of the page.SummaryDifference0.0%

- Check91 days agoChange Detected- Recruitment status updated to 'no longer looking for participants' indicates enrollment for this study is closed. - New help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and a template revision (Revision: v3.6.0) with a minor header formatting change for Intervention/Treatment were included.SummaryDifference0.2%

Stay in the know with updates to Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial page.